Department of Medicine

University of Pittsburgh

G. David Roodman, MD, PhD
photo

Professor of Medicine

Vice Chair for Research

Director of the Center for Bone Biology at UPMC

Director of the Myeloma Program at UPCI
Office: VA Pittsburgh Healthcare System
R&D (151C-U), Rm 2E-113, University Dr. C
Pittsburgh, PA 15240
 
Phone: 412-688-6571
Fax: 412-688-6960
E-mail: roodmangd@upmc.edu
Education
AB, The Johns Hopkins University, 1969
MD, University of Kentucky College of Medicine, 1973
PhD, University of Kentucky, 1975
Training
Intern in Medicine, University of Kentucky, 1976
Resident in Medicine, University of Minnesota, 1978
Fellow in Hematology, University of Minnesota, 1980
Area of Specialization/Research Interest  
Multiple Myeloma
Paget's Disease
 
Profile
G. David Roodman, MD, PhD is Vice Chair for Research in the Department of Medicine, and Professor of Medicine, Hematology/Oncology. He is Director of the Myeloma Program, UPCI; and Director of the Ctr. for Bone Biology at UPMC. Dr. Roodman holds four U.S. patents, two investigator initiated NIH grants and heads a Program Project Grant on Pathobiology of Paget’s Disease. This Program Project attempts to answer several important questions about the role measles virus play in the pathophysiology of Paget’s disease and the important role the genetic component plays in the pathologic process. The Department of Veterans Affairs Merit Review Grant and the Multiple Myeloma Research Foundation’s Collaborative Program Grant also fund his studies on myeloma bone disease. Dr. Roodman serves on several peer review editorial boards, including Experimental Hematology, Bone, Journal of Clinical Investigation, Endocrinology, and is an Associate Editor for the Journal of Bone and Mineral Research.
Recent Grants
Title: Osteoclasts from Transgenic Mice
Role: PI
Amount: 1,580,366
Funding Agency: NIH
Start Year: 2005
End Year: 2010
Title: Bone Microenvironmental Factors In Myeloma Bone Disease
Role: PI
Amount: 1,494,000
Funding Agency: Multiple Myeloma Research Foundation
Start Year: 2004
End Year: 2006
Title: Pathobiology of Paget’s Disease
Role: PI
Amount: 6,848,828
Funding Agency: NIH/NIAMS
Start Year: 2003
End Year: 2008
Title: Role of MIP-1 Alpha in Myeloma Bone Disease
Role: PI
Amount: 672,500
Funding Agency: Veteran's Administration
Start Year: 2001
End Year: 2006
Title: Developmental Aspects of Osteoclast Formation In Vitro
Role: PI
Amount: 1,278,060
Funding Agency: NIH/NIA
Start Year: 2001
End Year: 2006
For Pub Med search results, click here.